Qiuzhe Guo

Dr. Qiuzhe Guo


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
YFYan Fang
Yan Fang
CXChuang Xiao
Chuang Xiao
LWLueli Wang
Lueli Wang
YWYoulan Wang
Youlan Wang
JZJun Zeng
Jun Zeng
YWYang Weimin
Yang Weimin
Background: Sepsis is initiated by the dysfunctional response of the host immune system to infection. Septic shock and acute lung injury (ALI) are the main etiology of death caused by sepsis. Glucocorticoids, which are commonly used in clinic to antagonize the inflammatory response of sepsis, may cause serious side effects. Isoforskolin (ISOF) from the plant Coleus forskohlii stimulates adenylyl cyclase, increases the cAMP level and inhibits inflammatory response. The aim of this study was to investigate the synergistic effect of ISOF with dexamethasone (DEX) to prevent and ameliorate septic inflammation. Methods: Lipopolysaccharide (LPS) of 30 and 5 mg/kg (iv.) was used to induce sepsis and ALI mice model respectively in vivo. BEAS-2B cells stimulated by LPS were applied as cell model in vitro. The cumulative survival of mice with LPS-induced sepsis and the histopathological changes of lungs in mice with acute lung injury were observed, and the secretion of pro-inflammatory cytokines was analyzed by ELISA. The expression of RGS2 in BEAS-2B cells was detected by immunoblotting assay and PCR. Results: In the sepsis mice model, ISOF (10 mg/kg) combined with DEX (10 mg/kg.) (ip.) pretreatment significantly increased mice survival rate from 33.3% to 58.3%, which was significantly higher than that of ISOF or DEX treated alone. In the ALI mice model, ISOF, DEX pretreatment alone and combined application attenuated pulmonary pathological changes in ALI mice. Furthermore, ISOF, DEX alone or combined administration decreased MPO, MDA, IL-6, and IL-8 levels, while significantly synergistic effects were observed in the combined treatment group compared with ISOF or DEX alone. In BEAS-2B cells, combined pretreatment with ISOF and DEX significantly decreased the expression of IL-8 and increased the expression of RGS2. Conclusion: The results indicated that ISOF in combination with DEX synergistically improves survival rate and attenuates ALI in mice model through anti-inflammatory and antioxidant effects.

31 October 2019 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
FYFangbing Yan
Fangbing Yan
SZShuyan Zhao
Shuyan Zhao
WWWenchao Wu
Wenchao Wu
ZXZhuxinyue Xie
Zhuxinyue Xie
QGQiuzhe Guo
Qiuzhe Guo

23 June 2021 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
QGQiuzhe Guo
Qiuzhe Guo
FYFangbing Yan
Fangbing Yan
POPeigang Ouyang
Peigang Ouyang
ZXZhuxinyue Xie
Zhuxinyue Xie
HWHaonan Wang
Haonan Wang
XPXiangbin Pan
Xiangbin Pan

25 January 2025
Verified
Book Chapter
Open access
PDF file
CYchao yang
chao yang
QGQiuzhe Guo
Qiuzhe Guo
HYHao Yu
Hao Yu
Yan ChenYan Chen
Yan Chen
TTTarik Taleb
Tarik Taleb
Kari TammiKari Tammi
Kari Tammi
Real-time data from diverse Internet of Things (IoT) sensors (such as cameras, temperature, light, and air quality sensors) is essential for monitoring smart manufacturing environments. However, efficiently perceiving, integrating, and interpreting this data remains a challenge, as it involves dealing with heterogeneous data formats, ensuring data accuracy, and providing real-time analytics. This paper proposes a semantic-enhanced Digital Twin (DT) to address these complexities and aims to offer a comprehensive view of industrial working environments. The paper first presents a conceptual overview of the semantic-enhanced DT architecture, followed by a detailed description of the system architecture, encompassing edge, cloud, and interface modules. Additionally, the implementation of the entire system is presented. The results demonstrate the feasibility of the proposed DT, showing its potential for deployment in real-world scenarios.

4 August 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
HLHaochang Lin
Haochang Lin
SWSha Wu
Sha Wu
ZWZhiying Weng
Zhiying Weng
HWHongyan Wang
Hongyan Wang
RSRui Shi
Rui Shi
YWYang Weimin
Yang Weimin
Objective. To reveal the molecular mechanism of the antagonistic effect of traditional Chinese medicine Tianma formula (TF) on dementia including vascular dementia (VaD) and Alzheimers disease (AD) and to provide a scientific basis for the study of traditional Chinese medicine for prevention and treatment of dementia. Method. The TF was derived from the concerted application of traditional Chinese medicine. We detected the pharmacological effect of TF in VaD rats. The molecular mechanism of TF was examined by APP/PS1 mice in vivo, Caenorhabditis elegans (C. elegans) in vitro, ELISA, pathological assay via HE staining, and transcriptome. Based on RNA-seq analysis in VaD rats, the differentially expressed genes (DEGs) were identified and then verified by quantitative PCR (qPCR) and ELISA. The molecular mechanisms of TF on dementia were further confirmed by network pharmacology and molecular docking finally. Results. The Morris water maze showed that TF could improve the cognitive memory function of the VaD rats. The ELISA and histological analysis suggested that TF could protect the hippocampus via reducing tau and IL-6 levels and increasing SYN expression. Meanwhile, it could protect the neurological function by alleviating Aβ deposition in APP/PS1 mice and C. elegans. In the RNA-seq analysis, 3 sphingolipid metabolism pathway-related genes, ADORA3, FCER1G, and ACER2, and another 5 nerve-related genes in 45 key DEGs were identified, so it indicated that the protection mechanism of TF was mainly associated with the sphingolipid metabolism pathway. In the qPCR assay, compared with the model group, the mRNA expressions of the 8 genes mentioned above were upregulated, and these results were consistent with RNA-seq. The protein and mRNA levels of ACER2 were also upregulated. Also, the results of network pharmacology analysis and molecular docking were consistent with those of RNA-seq analysis. Conclusion. TF alleviates dementia by reducing Aβ deposition via the ACER2-mediated sphingolipid signaling pathway.

18 March 2026 in Echocardiography
Verified
Journal Article
Open access
PDF file
WZWanyu Zhao
Wanyu Zhao
XDXiaoli Dong
Xiaoli Dong
XJXiangyu Ji
Xiangyu Ji
JTJiong Tang
Jiong Tang
LDLin Ding
Lin Ding
YSYan Shen
Yan Shen
Background: Coronary microvascular dysfunction (CMD) persists after percutaneous coronary intervention (PCI) in individuals with coronary artery disease (CAD). This study assessed CMD using combined dipyridamole‐exercise stress echocardiography (DExE) and myocardial strain/work to evaluate the impact on left ventricular (LV) function. Methods: This prospective study enrolled CAD individuals who underwent left anterior descending artery PCI and DExE assessment at 3 months post‐PCI to evaluate myocardial strain/work parameters at rest and stress. The primary endpoint was adverse clinical events, and the secondary endpoint was Seattle Angina Questionnaire (SAQ) health status at 1‐year. Results: The cohort comprised 84 individuals (54 ± 10 years, 17.9% female). Participants were stratified into two groups by coronary flow velocity reserve (CFVR): CFVR ≥ 2.5 group ( n = 63) and CFVR < 2.5 group ( n = 21). Compared with the CFVR ≥ 2.5 group, the CFVR < 2.5 group showed impaired LV functional reserve, with lower global longitudinal strain (GLS), global work index (GWI), and global work efficiency (GWE) at peak exercise and recovery, lower peak exercise global constructive work (GCW), higher recovery global wasted work (GWW), and smaller absolute changes ΔE—R (difference before vs. after exercise stress) in GLS, GWI, and GCW (all p < 0.05). In multivariable analysis, peak exercise GCW, recovery GWW, and ΔGCW (E − R) were independent predictors of CMD. At 1 year, no adverse clinical events occurred, and the CFVR ≥ 2.5 group had higher SAQ physical limitation (92.86 ± 11.38 vs. 82.14 ± 17.93), quality of life (95.63 ± 10.57 vs. 83.33 ± 19.90), and summary score (94.05 ± 8.51 vs. 85.71 ± 15.71) than the CFVR < 2.5 group (all p < 0.05). Conclusions: Combined DExE with myocardial strain/work analysis effectively evaluates LV function in CMD. Decreased CFVR post‐PCI is associated with impaired LV function and worse 1‐year quality of life outcomes, underscoring the need for close cardiac function monitoring in post‐PCI CMD individuals. Trial Registration: URL: https://www.chictr.org.cn/ ; Unique identifier: ChiCTR2500103229.